BNO Q Announcement. Patients and Patience.

Plenty of cash with $38 mln and revenue of $1.7 mln down slightly due to timing of receipts so expect higher next Q.
They expect to receive a R and D tax incentive refund of $6.8 mln which covers their expected expenditure for next q.

Highlights are data from clinical trials is expected by early 2nd half of 2018.
Also "We continue to progress potential partnership discussions"

The charts have bounced perfectly off that triple bottom ( a la Kim Kardashian) circa 40/41.5 cents and now looking to push higher , take out the old highs of 50.5 cents and with a great amount of patience needed we will see $1 plus.

DYOR, IMO etc.